Fragment 17-23

Also known as: Frag 17-23, GHK Fragment

A fragment of growth hormone with proposed anti-aging and metabolic effects.

Overview

Fragment 17-23 is a small peptide segment being researched for potential metabolic and anti-aging effects. It represents a specific region of a larger protein with isolated biological activity.

Mechanism of Action

Proposed selective activity on specific receptors. May have metabolic effects distinct from full parent molecule.

Pharmacokinetics

Short peptide with rapid clearance. Subcutaneous administration typical.

Dosing Protocols

Note: These are research protocols from literature. This is not medical advice.

1

Research

Dose

250-500 mcg

Frequency

1-2x daily

Duration

4-8 weeks

Experimental protocols

Stacking Recommendations

Peptides that may be combined based on complementary mechanisms in research settings.

Rationale: Anti-aging

Synergy: Multiple anti-aging pathways

Research Areas

MetabolismAnti-AgingBody CompositionCellular Health

Key Research Findings

  • 1Fragment with isolated biological activity
  • 2Research ongoing into specific mechanisms
  • 3Limited published clinical data

Side Effects & Contraindications

Reported Side Effects

  • Limited data available

Contraindications

  • Limited data - use caution

Safety Considerations

Research compound. Limited safety data available.

Storage Requirements

Refrigerate 2-8°C

Scientific References

Quick Reference

Sequence
7 amino acid fragment
Molecular Weight
~800 g/mol
Half-Life
Short
Bioavailability
Injectable
Research Stage
preclinical
Administration
Subcutaneous injection